Mat joined HGF in October 2017 to train as a Patent Attorney and is now a qualified UK and European Patent Attorney. He has a First Class Masters Degree in Chemistry from the University of Sheffield, as well as a PhD in Surface Chemistry from the same institution.
Mat’s doctoral research focussed on the development of self-assembled monolayers and their potential to create molecular-scale structures on surfaces. After completing his PhD, Mat worked as a Research Associate investigating polymer coatings as anti-fouling surfaces and nutrient-sensing layers.
Mat has experience in drafting and prosecuting patent applications with a wide range of chemical subject matter before the UK and European patent offices, including pharmaceutical formulations, agrochemicals, medical devices, functionalised surfaces and surface coatings, and nano-materials.
First Class, University of Sheffield (2010)
Nanochemistry / Surface Chemistry, University of Sheffield (2014)
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …Event details
Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …Event details
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.